Cytochrome Institute Inc
Nonprofit profile at a glance
- EIN
- 874051808
- IRS 990-EZ coverage
- 2023–2024
- Forms available
- Form 990-EZ 2024, Form 990-N 2022
- Location
- Groton, MA, USA
- Phone
- 9782720311
- Rating confidence
- Limited
- Sector
- Education N.E.C.
Reported finances
- Revenue
- $0
- Expenses
- $95
- Assets
- $226
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
1 person listed
Executive titles in this filing
- Samuel Bearg (President)
People named in this filing
- Samuel Bearg (President)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To provide education regarding Cytochrome P450 mutations and drug interactions. Our goal is to prevent harm caused by drug-drug, gene-drug, and food drug interactions.
What it reported doing in 2024
Provided freely accessible educational information to the public regarding drug-drug, gene-drug, and food-drug interactions, with emphasis on the Cytochrome P450 enzyme system. The organization disseminated this information through its website and other online platforms, responding to inquiries and promoting evidence-based awareness of potential interaction risks. Hundreds of individuals viewed our information.
Operating model
- Revenue model
- No positive adjusted resources. The filing reports no positive adjusted operating resources.
- Distribution model
- No current program activity. The filing reports no program spending for the current year.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: 0
- Transparency & Controls: 82
- Sustainability: 35
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: 0%; rating input score 0
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: Limited
- Total-asset coverage ratio: 2.38; rating input score 69; 69th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 68; 68th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: -200% per year; rating input score 0; 0th percentile among comparable filings
- Asset growth: -34.7% per year; rating input score 0; 6th percentile among comparable filings
Details
- Where the money goes: 0% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment
- Leadership: top reported pay $0 · 1 people listed
- Consistency: 9 of 9 current checks pass
- Schedules: 2 filed schedules
- Filing history: 2 filing years from 2023 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Financial Efficiency: Program expense ratio scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Growth: Asset growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.